CAT No: CP25167
CAS No:112883-42-8
Synonyms/Alias:112883-42-8;Fmoc-N-Me-Nle-OH;Fmoc-N-methyl-L-norleucine;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hexanoicacid;Fmoc-Nalpha-methyl-L-norleucine;AmbotzFAA6460;L-Norleucine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-;SCHEMBL119776;TMA044;CTK4A8010;MolPort-006-705-971;ZINC2560005;CF-828;MFCD00235878;AKOS015837161;CS11418;RTR-062402;AJ-40413;AK-85719;SC-89920;KB-300453;TR-062402;FT-0689530;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-norleucine;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}hexanoicacid
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-L-norleucine
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.